' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

PINON HOFBAUER JOSEFINA
Forschungsprogramm für Molekulare Therapie bei Genodermatosen

Publikationen | Forscherprofil

66 Publikationen

2019

Beiträge in Fachzeitschriften

Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Atanasova, VS; Pourreyron, C; Farshchian, M; Lawler, ME; Brown, CA; Watt, S; Wright, S; Warkala, M; Guttmann-Gruber, C; Pinon-Hofbauer, J; Fuentes, I; Prisco, M; Rashidghamat, E; Has, C; Salas-Alanis, JC; Palisson, F; Hovnanian, A; McGrath, JA; Mellerio, J; Bauer, JW; South, AP;
Clin Cancer Res. 2019; 25(11):3384-3391
Originalarbeiten (Zeitschrift)
Gene editing-mediated disruption of epidermolytic ichthyosis-associated KRT10 alleles restores filament stability in keratinocytes.
March, OP; Lettner, T; Klausegger, A; Ablinger, M; Kocher, T; Hainzl, S; Peking, P; Lackner, N; Rajan, N; Hofbauer, JP; Guttmann-Gruber, C; Bygum, A; Koller, U; Reichelt, J;
J Invest Dermatol. 2019;
Originalarbeiten (Zeitschrift)

2018

Beiträge in Fachzeitschriften

APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho, RJ; Alexandrov, LB; den Breems, NY; Atanasova, VS; Farshchian, M; Purdom, E; Nguyen, TN; Coarfa, C; Rajapakshe, K; Prisco, M; Sahu, J; Tassone, P; Greenawalt, EJ; Collisson, EA; Wu, W; Yao, H; Su, XP; Guttmann-Gruber, C; Hofbauer, JP; Hashmi, R; Fuentes, I; Benz, SC; Golovato, J; Ehli, EA; Davis, CM; Davies, GE; Covington, KR; Murrell, DF; Salas-Alanis, JC; Palisson, F; Bruckner, AL; Robinson, W; Has, C; Bruckner-Tuderman, L; Titeux, M; Jonkman, MF; Rashidghamat, E; Lwin, SM; Mellerio, JE; McGrath, JA; Bauer, JW; Hovnanian, A; Tsai, KY; South, AP
SCI TRANSL MED. 2018; 10(455):
Originalarbeiten (Zeitschrift)
Reduced Microbial Diversity Is a Feature of Recessive Dystrophic Epidermolysis Bullosa-Involved Skin and Wounds.
Fuentes, I; Guttmann-Gruber, C; Ling Tay, AS; Hofbauer, JP; Denil, SLIJ; Reichelt, J; Palisson, F; Common, JEA; South, AP;
J Invest Dermatol. 2018; 138(11): 2492-2495.
Letter
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U;
Int J Mol Sci. 2018; 19(3):
Originalarbeiten (Zeitschrift)
Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
Morio, H; Sun, YC; Harada, M; Ide, H; Shimozato, O; Zhou, XJ; Higashi, K; Yuki, R; Yamaguchi, N; Hofbauer, JP; Guttmann-Gruber, C; Anzai, N; Akita, H; Chiba, K; Furihata, T
BIOL PHARM BULL. 2018; 41(3): 445-449.
Originalarbeiten (Zeitschrift)
Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun, Y; Hofbauer, JP; Harada, M; Wöss, K; Koller, U; Morio, H; Stierschneider, A; Kitamura, K; Hashimoto, M; Chiba, K; Akita, H; Anzai, N; Reichelt, J; Bauer, JW; Guttmann-Gruber, C; Furihata, T;
Cancer Lett. 2018; 433: 107-116.
Originalarbeiten (Zeitschrift)
Extracellular Vesicles as Biomarkers for the Detection of a Tumor Marker Gene in Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Sun, Y; Woess, K; Kienzl, M; Leb-Reichl, VM; Feinle, A; Wimmer, M; Zauner, R; Wally, V; Luetz-Meindl, U; Mellerio, JE; Fuentes, I; South, AP; Bauer, JW; Reichelt, J; Furihata, T; Guttmann-Gruber, C; Piñón Hofbauer, J;
J Invest Dermatol. 2018; 138(5):1197-1200
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Cancer-type SLCO1B3 as a biomarker for epidermolysis bullosa-associated skin cancer
Guttmann-Gruber, C; Woss, K; Sun, Y; Furihata, T; Reichelt, J; Hofbauer, JP
J INVEST DERMATOL. 2018; 138(5): S38-S38.
Abstracts (Zeitschrift)
Metformin exerts anti-neoplastic effects against human and murine squamous cell carcinoma
Welponer, T; Trattner, L; Bauer, JW; Reichelt, J; Kofler, B; Hofbauer, JP; Guttmann-Gruber, C
J INVEST DERMATOL. 2018; 138(5): S84-S84.
Abstracts (Zeitschrift)

2017

Beiträge in Fachzeitschriften

Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
Atanasova, VS; Jiang, Q; Prisco, M; Gruber, C; Hofbauer, JP; Chen, M; Has, C; Bruckner-Tuderman, L; McGrath, JA; Uitto, J; South, AP
J INVEST DERMATOL. 2017; 137(9): 1842-1849.
Originalarbeiten (Zeitschrift)
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U;
Mol Ther. 2017; 25(11):2585-2598
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes
Kocher, T; Peking, P; Klausegger, A; Murauer, EM; Hofbauer, JP; Wally, V; Lettner, T; Hainzl, S; Ablinger, M; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A57-A57.
Abstracts (Zeitschrift)
Viral antigen-specific pre-vaccination prevents engraftment of tumor cells expressing the cognate antigen in mice
Leb-Reichl, V; Kienzl, M; Stoecklinger, A; Kitzmueller, S; Gratz, IK; Brachtl, G; Zaborsky, N; Reichelt, J; Gruber, C; Hofbauer, JP
J INVEST DERMATOL. 2017; 137(10): S286-S286.
Abstracts (Zeitschrift)
Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2017; 137(10): S229-S229.
Abstracts (Zeitschrift)
Enhanced genome editing using split Staphylococcus aureus Cas9 delivered in self-complementary AAV vectors
Liemberger, B; Arzt, C; Hainzl, S; Wally, V; Kocher, T; Hofbauer, JP; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2017; 28(12): A63-A63.
Abstracts (Zeitschrift)
Extracellular vesicles as biomarkers for the detection of epidermolysis bullosa-associated squamous cell carcinoma
Sun, Y; Woess, K; Wimmer, M; Zauner, R; Feinle, A; Wally, V; South, A; Furihata, T; Hofbauer, JP; Gruber, C
J INVEST DERMATOL. 2017; 137(10): S288-S288.
Abstracts (Zeitschrift)

2016

Beiträge in Fachzeitschriften

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.
Hofbauer, SW; Krenn, PW; Piñόn Hofbauer, J; Pucher, S; Asslaber, D; Egle, A; Hartmann, TN; Greil, R;
Br J Haematol. 2016; 172(5):815-819
Letter
CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.
Kocher, T; Asslaber, D; Zaborsky, N; Flenady, S; Denk, U; Reinthaler, P; Ablinger, M; Geisberger, R; Bauer, JW; Seiffert, M; Hartmann, TN; Greil, R; Egle, A; Piñón Hofbauer, J;
Leukemia. 2016; 30(6):1409-1413
Letter
CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
Zaborsky, N; Gassner, FJ; Asslaber, D; Reinthaler, P; Denk, U; Flenady, S; Hofbauer, JP; Danner, B; Rebhandl, S; Harrer, A; Geisberger, R; Greil, R; Egle, A;
Oncotarget. 2016; 7(31):4945-49469
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Calcipotriol treatment increases low levels of cathelicidin expression and enhances anti-microbial activity of recessive dystrophic epidermolysis bullosa keratinocytes
Gruber, C; Hofbauer, JP; Tockner, B; Huttner, C; Breitenbach, JS; Trost, A; Leb-Reichl, VM; Klausegger, A; Hainzl, S; Reichelt, J; Bauer, JW; Lang, R
EXP DERMATOL. 2016; 25(3): E12-E12.
Abstracts (Zeitschrift)
Developing a cancer immunogene therapy approach for Epidermolysis bullosa-associated squamous cell carcinoma
Kienzl, M; Leb-Reichl, V; Stoecklinger, A; Tockner, B; Gratz, IK; Bauer, JW; Reichelt, J; Gruber, C; Hofbauer, JP
J INVEST DERMATOL. 2016; 136(9): S242-S242.
Abstracts (Zeitschrift)
Antisense RNA-mediated improvement of SMaRT therapy for KRT14 correction
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
HUM GENE THER. 2016; 27(11): A135-A135.
Abstracts (Zeitschrift)
Combining antisense molecules with splicing modulation for KRT14 repair in epidermolysis bullosa
Liemberger, B; Arzt, C; Hainzl, S; Hofbauer, JP; Wally, V; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U
J INVEST DERMATOL. 2016; 136(9): S189-S189.
Abstracts (Zeitschrift)
Evaluation of the immunogenicity of viral epitopes in a cancer immunogene therapy approach for squamous cell carcinoma in RDEB
Reichl, VM; Kienzl, M; Stocklinger, A; Tockner, B; Reichelt, J; Gruber, C; Pinon-Hofbauer, J
MELANOMA RES. 2016; 26: E107-E107.
Abstracts (Zeitschrift)
Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP
MOL BIOL CELL. 2016; 27:
Abstracts (Zeitschrift)
Targeting tumor metabolism in the therapy of aggressive squamous cell carcinoma in patients with epidermolysis bullosa
Welponer, T; Hofbauer, JP; Gruber, C; Kienzl, M; Aminzadeh-Gohari, S; Feichtinger, R; Lang, R; Bauer, JW; Kofler, B; Reichelt, J
MELANOMA RES. 2016; 26: E77-E77.
Abstracts (Zeitschrift)

2015

Beiträge in Fachzeitschriften

Can we be SMaRT-er in our approach to cancer therapy?
Gruber, C; Hofbauer, JP; Bauer, JW;
EBioMedicine. 2015; 2(7): 621-622.
Kurzberichte/Notes
B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.
Zaborsky, N; Holler, C; Geisberger, R; Asslaber, D; Gassner, FJ; Egger, V; Piñón-Hofbauer, J; Kocher, T; Hartmann, TN; Greil, R; Egle, A;
Haematologica. 2015; 100(8):e307-e310
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Pathological mechanisms underlying contracture formation in epidermolysis bullosa
Liemberger, B; Hainzl, S; Koller, U; Wally, V; Hofbauer, JP; Studnicka-Benke, A; Diem, A; Bauer, J; Breitenbach, J; Gruber, C
J INVEST DERMATOL. 2015; 135: S59-S59.
Abstracts (Zeitschrift)

2014

Beiträge in Fachzeitschriften

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl, G; Piñón Hofbauer, J; Greil, R; Hartmann, TN;
Ann Hematol. 2014; 93(3): 361-374.
Übersichtsarbeiten
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Grössinger, EM; Weiss, L; Zierler, S; Rebhandl, S; Krenn, PW; Hinterseer, E; Schmölzer, J; Asslaber, D; Hainzl, S; Neureiter, D; Egle, A; Piñón-Hofbauer, J; Hartmann, TN; Greil, R; Kerschbaum, HH;
Leukemia. 2014; 28(4):954-958
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The Transcription Factor IRF4 Is Crucial for CLL Progression and Regulates Survival and Proliferation in a Microenvironment Related Manner
Asslaber, D; Hofbauer, JP; Zaborsky, N; Flenady, S; Hartmann, TN; Greil, R; Egle, A
BLOOD. 2014; 124(21):
Abstracts (Zeitschrift)
The Spiegelmer (R) NOX-A12 Mobilizes CLL Cells from Lymphoid Organs and Prevents Their Recirculation
Hinterseer, E; Girbl, T; Hutterer, E; Berghammer, P; Ganghammer, S; Sifft, EA; Pinon-Hofbauer, J; Egle, A; Kruschinski, A; Greil, R; Hartmann, TN
SCAND J IMMUNOL. 2014; 79(6): 468-469.
Abstracts (Zeitschrift)

2013

Beiträge in Fachzeitschriften

Bid-ding for mercy: twisted killer in action.
Egle, A; Asslaber, D; Villunger, A; Pinon-Hofbauer, J;
Cell Death Differ. 2013; 20(7):847-849
Editorials
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente, LJ; Gray, DH; Michalak, EM; Pinon-Hofbauer, J; Egle, A; Scott, CL; Janic, A; Strasser, A;
Cell Rep. 2013; 3(5):1339-1345
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

The transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival
Asslaber, D; Hofbauer, JP; Zaborsky, N; Kocher, T; Hartmann, TN; Greil, R; Egle, A
ONKOLOGIE. 2013; 36: 222-223.
Abstracts (Zeitschrift)
Blockade of the Potassium Channel KCa3.1 inhibits proliferation in Chronic Lymphocytic Leukemia
Grossinger, EM; Weiss, L; Zierler, S; Hinterseer, E; Schmolzer, J; Asslaber, D; Hainzl, S; Egle, A; Pinon, JD; Hartmann, TN; Greil, R; Kerschbaum, HH
ONKOLOGIE. 2013; 36: 191-192.
Abstracts (Zeitschrift)
Antiapoptotic effects of p21 regarding its subcellular localization in arsenic trioxide induced apoptosis in CLL
Sifft, E; Hofbauer, JP; Asslaber, D; Hartmann, TN; Merkel, O; Greil, R
ONKOLOGIE. 2013; 36: 222-222.
Abstracts (Zeitschrift)

2012

Beiträge in Fachzeitschriften

Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
Merkel, O; Wacht, N; Sifft, E; Melchardt, T; Hamacher, F; Kocher, T; Denk, U; Hofbauer, JP; Egle, A; Scheideler, M; Schlederer, M; Steurer, M; Kenner, L; Greil, R;
Leukemia. 2012; 26(12):2508-2516
Originalarbeiten (Zeitschrift)

2011

Beiträge in Fachzeitschriften

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN;
PLoS One. 2011; 6(8):e23758
Originalarbeiten (Zeitschrift)
Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia.
Gassner, FJ; Weiss, L; Geisberger, R; Hofbauer, JP; Egle, A; Hartmann, TN; Greil, R; Tinhofer, I;
Cancer Immunol Immunother. 2011; 60(1):7-85
Originalarbeiten (Zeitschrift)
Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
Hofbauer, JP; Heyder, C; Denk, U; Kocher, T; Holler, C; Trapin, D; Asslaber, D; Tinhofer, I; Greil, R; Egle, A;
Leukemia. 2011; 25(9): 1452-1458.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

CLL CELLS INDUCE CLONAL T CELL SKEWING AND SUBSETSHIFTING IN THE MURINE TCL1 TRANSGENIC CHRONIC LYMPHOCYTIC LEUKEMIA MODEL
Egle, A; Pinon-Hofbauer, J; Heyder, C; Denk, U; Kocher, T; Holler, C; Trapin, D; Asslaber, D; Tinhofer, I; Greil, R
ANN ONCOL. 2011; 22: 144-144.
Abstracts (Zeitschrift)
Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia
Holler, C; Zaborsky, N; Hofbauer, JP; Kocher, T; Trapin, D; Asslaber, D; Greil, R; Egle, A
BLOOD. 2011; 118(21): 365-365.
Abstracts (Zeitschrift)
Tumor load reduction and prolongation of overall-survival by actinomycin D in a murine model of high-risk chronic lymphocytic leukemia
Wacht, N; Sifft, E; Melchardt, T; Hamacher, F; Denk, U; Pinon-Hofbauer, J; Egle, A; Kocher, T; Steurer, M; Greil, R; Merkel, O
ONKOLOGIE. 2011; 34: 141-141.
Abstracts (Zeitschrift)

2010

Beiträge in Fachzeitschriften

MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer.
Asslaber, D; Pinon Hofbauer, J; Greil, R; Egle, A
Journal of nucleic acids investigation. 2010; Dec 1, 1(1): 76-80.
Originalarbeiten (Zeitschrift)
microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber, D; Piñón, JD; Seyfried, I; Desch, P; Stöcher, M; Tinhofer, I; Egle, A; Merkel, O; Greil, R;
Blood. 2010; 115(21):4191-4197
Originalarbeiten (Zeitschrift)
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer, SW; Piñón, JD; Brachtl, G; Haginger, L; Wang, W; Jöhrer, K; Tinhofer, I; Hartmann, TN; Greil, R;
Cancer Res. 2010; 70(18):7336-7344
Originalarbeiten (Zeitschrift)
Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation.
Labi, V; Erlacher, M; Krumschnabel, G; Manzl, C; Tzankov, A; Pinon, J; Egle, A; Villunger, A;
Genes Dev. 2010; 24(15):1602-1607
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

VLA-4 and CD38 in chronic lymphocytic leukemia - more than prognostic markers?
Brechtl, G; Denk, U; Pinon-Hofbauer, JD; Greil, R; Hartmann, TN
ONKOLOGIE. 2010; 33: 201-202.
Abstracts (Zeitschrift)
Deletion of Puma and p21(Waf1) In Mice Deactivates p53-Induced Cell Death and Cell Cycle Arrest, but Protects Mice From Irradiation-Induced Lymphomagenesis by a Mechanism Involving Hemopoietic Stem Cell Quiescence
Hofbauer, JP; Holler, C; Denk, U; Asslaber, D; Fastner, G; Labi, V; Villunger, A; Greil, R; Egle, A
BLOOD. 2010; 116(21): 45-46.
Abstracts (Zeitschrift)
Enzastaurin kills human CLL cells regardless of clinical risk profile, but fails to prolong life in a murine CLL model
Kocher, T; Pinon, HJ; Holler, C; Denk, U; Greil, R; Egle, A
ONKOLOGIE. 2010; 33: 40-40.
Abstracts (Zeitschrift)
Tumour suppression by BH3-only proteins, proapoptotic members of the Bcl-2 family
Villunger, A; Labi, V; Frenzel, A; Egle, A; Pinon, J
EJC SUPPL. 2010; 8(5): 1-1.
Abstracts (Zeitschrift)

2009

Beiträge in Fachzeitschriften

PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
Holler, C; Piñón, JD; Denk, U; Heyder, C; Hofbauer, S; Greil, R; Egle, A;
Blood. 2009; 113(12):2791-2794
Originalarbeiten (Zeitschrift)

2008

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

T Cell Dynamics during the Pretumor and Tumor Phase in the Murine Tcll Transgenic Chronic Lymphocytic Leukemia Model
Egle, A; Pinon, JD; Heyder, C; Holler, C; Denk, U; Tinhofer, I; Greil, R
BLOOD. 2008; 112(11): 1078-1078.
Abstracts (Zeitschrift)

2003

Beiträge in Fachzeitschriften

An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.
Piñón, JD; Kelly, SM; Price, NC; Flanagan, JU; Brighty, DW;
J Virol. 2003; 77(5):3281-3290
Originalarbeiten (Zeitschrift)
Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
Piñon, JD; Klasse, PJ; Jassal, SR; Welson, S; Weber, J; Brighty, DW; Sattentau, QJ;
J Virol. 2003; 77(18):9922-9930
Originalarbeiten (Zeitschrift)
Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system.
Tsai, JC; de Groot, L; Pinon, JD; Iacono, KT; Phillips, JJ; Seo, SH; Lavi, E; Weiss, SR;
Virology. 2003; 312(2):369-380
Originalarbeiten (Zeitschrift)

2001

Beiträge in Fachzeitschriften

Pathogenesis of fusion deficient recombinant mouse hepatitis viruses.
De Groot, L; Piñón, JD; Phillips, J; Lavi, E; Weiss, SR;
Adv Exp Med Biol. 2001; 494:159-162
Kurzberichte/Notes

1999

Beiträge in Fachzeitschriften

Localization of mouse hepatitis virus open reading frame 1A derived protein (vol 4, pg 594, 1998)
Bi, WZ; Pinon, JD; Hughes, S; Bonilla, PJ; Holmes, KV; Weiss, SR; Leibowitz, JL
J NEUROVIROL. 1999; 5(2): 215-216.
Korrekturen
Further requirements for cleavage by the murine coronavirus 3C-like proteinase: identification of a cleavage site within ORF1b.
Piñón, JD; Teng, H; Weiss, SR;
Virology. 1999; 263(2):471-484
Originalarbeiten (Zeitschrift)
Expression of murine coronavirus recombinant papain-like proteinase: efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides.
Teng, H; Piñón, JD; Weiss, SR;
J Virol. 1999; 73(4):2658-2666
Originalarbeiten (Zeitschrift)

1998

Beiträge in Fachzeitschriften

Localization of mouse hepatitis virus open reading frame 1A derived proteins.
Bi, W; Piñón, JD; Hughes, S; Bonilla, PJ; Holmes, KV; Weiss, SR; Leibowitz, JL;
J Neurovirol. 1998; 4(6):594-605
Originalarbeiten (Zeitschrift)

1997

Beiträge in Fachzeitschriften

Efficient autoproteolytic processing of the MHV-A59 3C-like proteinase from the flanking hydrophobic domains requires membranes.
Piñón, JD; Mayreddy, RR; Turner, JD; Khan, FS; Bonilla, PJ; Weiss, SR;
VIROLOGY. 1997; 230(2): 309-322.
Originalarbeiten (Zeitschrift)

1995

Beiträge in Fachzeitschriften

Characterization of the leader papain-like proteinase of MHV-A59: identification of a new in vitro cleavage site.
Bonilla, PJ; Hughes, SA; Piñón, JD; Weiss, SR;
VIROLOGY. 1995; 209(2): 489-497.
Originalarbeiten (Zeitschrift)